Employing Au@PG nanoparticles in lung cancer immunotherapy resulted in the promising polarization activity of M1 macrophage and the promotion of the cytotoxic T cell response as well as tumor inhibition and the secretion of immunogenic cytokines when combined with PD-1 therapy (Su et al., 2022). The gene discussed is PDCD1; the disease is lung cancer.